BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

  Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced today at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.

  February 12, 2019

   · 

  4 min read
• Business

  7wireVentures Welcomes Alyssa Jaffee as Vice President

  7wireVentures, Chicago’s premier early stage consumer digital health venture firm, today announced that Alyssa Jaffee has joined as Vice President.

  February 12, 2019

   · 

  2 min read
• Biotech Bay

  Halley Venture Partners LP, a San Francisco-based Venture Capital Firm Focusing on Cannabis Technology Companies, Has Announced an $8 Million Anchor Investment

  HALLEY Venture Partners LP, a San Francisco-based venture capital firm focusing on cannabis-related technology companies, has announced an $8 million capital commitment from an East Coast-based single family office with decades of investment management experience.

  February 12, 2019

   · 

  2 min read
• Business

  Trialbee Signs Two Top Ten Pharmaceutical Companies for Its Patient-Matching and Engagement Platforms

  Trialbee, a world leading technology provider in patient matching and engagement announces two commercial milestones with two of the top 10 pharma companies.

  February 12, 2019

   · 

  2 min read
• Biotech Beach

  Axonics® Submits Full Body MRI Data to U.S. Food & Drug Administration for its Sacral Neuromodulation System

  Axonics Modulation Technologies, Inc. announced the submission of complete test data to the U.S. Food & Drug Administration for the purpose of gaining Conditional Full Body Magnetic Resonance Imaging labeling approval for the Axonics r-SNM® System1 for urinary and bowel dysfunction.

  February 12, 2019

   · 

  5 min read
• BioMidwest

  Combined cost of winter storms and extreme cold lead to billion-dollar damage in the U.S. -- Aon catastrophe report

  Aon plc, a leading global professional services firm providing a broad range of risk, retirement and health solutions, has launched its Global Catastrophe Recap – January 2019.

  February 12, 2019

   · 

  2 min read
• Mallinckrodt To Present At Barclays Global Healthcare Conference

  Mallinckrodt Pharmaceuticals, a leading global specialty pharmaceutical company, will present on Tuesday, March 12, 2019, at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel, 1601 Collins Ave, Miami Beach, Fla.

  February 12, 2019

   · 

  1 min read
• Business

  TransEnterix Schedules Fourth Quarter and Fiscal Year 2018 Financial and Operating Results Conference Call for February 26, 2019

  TransEnterix, Inc. announced that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019.

  February 12, 2019

   · 

  1 min read
• Business

  Supreme Cannabis Announces Q2 2019 Financial Results

  The Supreme Cannabis Company, Inc., announced the release of its financial and operating results for the three and six months ended December 31, 2018.

  February 12, 2019

   · 

  6 min read
• BioCapital

  Survey: Patients Prefer Secure Texting Over Patient Portal Communication From Their Physicians

  Patients welcome text messages that encourage better health, and family members prefer text message updates about loved ones

  February 12, 2019

   · 

  3 min read